Study Summary
This trial will see if patients with some kidney function will do better with two hemodialysis treatments a week, instead of the usual three.
Eligible Conditions
- Hemodialysis
- Chronic Kidney Failure
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: 4 weeks
4 weeks
Cognition
QOL: KDQOL36
Solute Concentration
Symptom
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
50 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks
Who is running the clinical trial?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,148 Previous Clinical Trials
4,074,699 Total Patients Enrolled
Palo Alto Veterans Institute for ResearchLead Sponsor
50 Previous Clinical Trials
8,206 Total Patients Enrolled
Tammy Sirich, MDPrincipal Investigator - Stanford/VA Palo Alto Health Care System
Palo Alto Veterans Institute for Research
Eligibility Criteria
Age 18 - 85 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments